Quest Diagnostics

Quest Diagnostics Liabilities

The The Liabilities of Quest Diagnostics (DGX) as of Nov 22, 2026 is 8.94 B USD. In the previous year, The Liabilities was 9.26 B USD — a change of -3.44% (lower).

Liabilities

8.94 BUSD

YoY

-3.44%

Last updated:

In 2025, Quest Diagnostics's total liabilities amounted to 8.94 B USD, a -3.44% difference from the 9.26 B USD total liabilities in the previous year.

The Quest Diagnostics Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
5.66 B USD
Jan 1, 2019
7.08 B USD
Jan 1, 2020
7.14 B USD
Jan 1, 2021
7.05 B USD
Jan 1, 2022
6.83 B USD
Jan 1, 2023
7.60 B USD
Jan 1, 2024
9.26 B USD
Jan 1, 2025
8.94 B USD
The Quest Diagnostics Liabilities history
YEARLiabilitiesYoY
8.94 BUSD-3.44%
9.26 BUSD+21.74%
7.60 BUSD+11.33%
6.83 BUSD-3.11%
7.05 BUSD-1.21%
7.14 BUSD+0.78%
7.08 BUSD+25.11%
5.66 BUSD+3.49%
5.47 BUSD+1.96%
5.36 BUSD+3.55%
5.18 BUSD-6.63%
5.55 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quest Diagnostics Stock analysis

What does Quest Diagnostics do? Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Quest Diagnostics's Liabilities

Quest Diagnostics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Quest Diagnostics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Quest Diagnostics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Quest Diagnostics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Quest Diagnostics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Quest Diagnostics stock

The Liabilities of Quest Diagnostics is 8.94 B USD in 2025.

The Liabilities of Quest Diagnostics changed from 9.26 B USD to 8.94 B USD, representing a -3.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Quest Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Quest Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Quest Diagnostics

All Key Metrics — Quest Diagnostics